Stocklytics Platform
BioCryst Pharmaceuticals
BCRX63
$7.54arrow_drop_down2.20%-$0.16
BCRX63

$7.54

arrow_drop_down2.20%

Analyst Forecast

no data available for Analyst Forecast

There's no data available for Analyst Forecast

Period: -

• Predicted: -

Analyst Ratings

no data available for Analyst Ratings

There's no data available for Analyst Ratings

Last updated: -

• Total: -

BioCryst Pharmaceuticals (BCRX) Stocklytics Forecast

BioCryst Pharmaceuticals Inc (BCRX) is a biotechnology company that focuses on the development of small molecule drugs for rare diseases. The company's mission is to deliver innovative therapies that can make a meaningful difference in the lives of patients. With a strong pipeline of drug candidates targeting various diseases, BioCryst is well-positioned for future growth.
One of the key factors driving the stock price of BioCryst Pharmaceuticals is the company's robust pipeline. The company has several promising drug candidates in advanced stages of development, and if successful, these drugs could generate significant revenue for the company. Furthermore, BioCryst has a strong track record of obtaining regulatory approvals for its drugs, which instills confidence in investors and analysts alike.
add BioCryst Pharmaceuticals to watchlist

Keep an eye on BioCryst Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for BioCryst Pharmaceuticals (BCRX) stock?

Analysts have set a target price of $14.14 for BioCryst Pharmaceuticals (BCRX), based on forecasts from 28 analysts. The predicted price range extends from a high of $30 to a low of $9. This represents a potential increase of up to 297.88% and a decrease of 19.36% from the current price of $7.54. These forecasts are as of 2022 Apr 12.
help

What are the analyst ratings for BioCryst Pharmaceuticals (BCRX) stock?

Currently, there are no analyst ratings available for BioCryst Pharmaceuticals (BCRX), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for BioCryst Pharmaceuticals (BCRX) stock?

At present, there is no AI or machine-learning-based price prediction available for BioCryst Pharmaceuticals (BCRX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level